Our study demonstrated that YM529 showed direct anti-tumor effect on NSCLC cell lines in vitro and induced apoptosis and G1 arrest cell cycle through down regulation of phospholyration of ERK1/2. The gene discussed is MAPK3; the disease is non-small cell lung carcinoma.